Table 1 |
||||
|
|
||||
|
Active disease (n = 8) (%) |
Inactive disease (n = 10) (%) |
Other rheumatic diseases (n = 4) (%) |
Healthy controls (n = 3) (%) |
|
|
|
||||
|
TLR-9 in lymphocytes |
64 ± 18 |
19 ± 14 |
22 ± 21 |
28 ± 3 |
|
TLR-9 in CD19+ cells |
42 ± 20 |
25 ± 24 |
17 ± 14 |
33 ± 5 |
|
TLR-9 in CD14+ cells |
31 ± 18 |
16 ± 13 |
6 ± 5 |
24 ± 13 |
|
|
||||
|
Papadimitraki et al. Arthritis Research & Therapy 2005 7(Suppl 1):P144 doi:10.1186/ar1665 |
||||